TGFB1 and endometriosis: reported that platelet-derived TGF-β1 suppresses the expression of NK Group 2, Member D (NKG2D), a KAR on NK cells, contributing to the reduced cytotoxicity of NK cells in women with endometriosis, while the neutralization of TGF-β1 reverses the reduction (80).